Intravitreal bevacizumab (Avastin) versus triamcinolone (Volon A) for treatment of diabetic macular edema: one-year resultsKatharina Kriechbaum, Ursula Schmidt‐Erfurth, Gregor Rainer et al.|Eye|2013Cited by 54
Response of Retinal Sensitivity to Intravitreal Anti-angiogenic Bevacizumab and Triamcinolone Acetonide for Patients with Diabetic Macular Edema over One YearGeorgios Mylonas, Katharina Kriechbaum, Markus Schranz et al.|Current Eye Research|2020Cited by 7